Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

The Latest Breaking News from Moderna

Get fourth COVID booster now, or wait? CDC says get the shot now, but many hesitate

About 70% of Americans 50 and older who got a first booster shot — and nearly as many of those 65 and older — haven’t gotten their second booster dose, the CDC says.

Chicago Sun-Times

COVID-19 vaccine Moderna is provisionally approved for kids under 5. This is what we know

Australian children aged six months to five years could soon be rolling up their sleeves for a COVID-19 jab. Here's what parents need to know.

ABC News

Novavax COVID shot for adults gains CDC advisers’ backing

Novavax Inc.’s shares surged after its COVID-19 vaccine won backing from a panel of U.S. public health advisers, a crucial step in providing officials with another tool against the virus as cases start to rise again.

Tribune News Service

From analysis to the latest developments in health,
read the most diverse news in one place.

Moderna Whale Trades Spotted

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 23 strange trades.

Benzinga

Covid vaccine provisionally approved in Australia for children aged six months to six years

Moderna’s paediatric dose will become available only after Australian Technical Advisory Group on Immunisation gives advice

The Guardian - AU

Check Out What Whales Are Doing With MRNA

Someone with a lot of money to spend has taken a bearish stance on Moderna (NASDAQ:MRNA). And retail traders should know. We noticed this today when the big position showed up on publicly available options history that we track here at Benzinga.

Benzinga

A dire moment in the pandemic ... was the chance he'd been waiting for

How Sotiris Missailidis, head of R&D in Brazil's vaccine agency, used the COVID crisis to push through a game-changing effort for middle-income countries to invent their own mRNA vaccine.

WEKU

Read news from The Economist, FT, and more,
with one subscription

Covid vaccine protection ‘short lived,’ booster doses essential, study confirms

‘Continual updating of our vaccinations and booster shots is critical,’ scientists say

The Independent UK

Australia has ordered millions more COVID vaccines than it needs. What are the options to deal with them?

Australia has used less than a quarter of the hundreds of millions of COVID-19 vaccine doses it bought. What will happen to the rest?

ABC News

Here's How To Trade This Pattern On BlackBerry, Moderna And Palantir Stocks

BlackBerry Ltd (NYSE: BB), Moderna Inc (NASDAQ: MRNA) and Palantir Technologies Inc (NYSE: PLTR) have been showing strength in

Benzinga

NOT REAL NEWS: A look at what didn't happen this week

Social media users shared a range of false claims this week

The Independent UK

COVID-19 vaccines targeting the Omicron variant are on the way — but it could be worth getting a fourth dose now

Omicron is now the dominant strain of COVID-19 around the world and boosters targeting this variant are getting closer to being released.

ABC News

The public deserves a return on the medicines governments support

Public money directly and indirectly supports pharmaceutical innovation. Governments need to ensure the public gets a fair return on its investment.

360info

Novavax’s COVID vaccine gets US nod as latest pandemic weapon

Novavax Inc.’s COVID-19 vaccine was cleared by U.S. regulators, giving Americans another tool against the virus as cases start to rise again.

Tribune News Service

Get all your
news in one place.

100's of premium titles.
One news app.

WEKU

These Brazilian besties are inventing an mRNA vaccine as a gift to the world

Pfizer and Moderna have refused to divulge details of how to make their cutting-edge COVID shots. Here's what two scientists — and longtime best friends — are doing about it.

Benzinga

Moderna Whale Trades Spotted

ABC News

Experts say there are a number of factors to weigh up about getting a fourth dose of a COVID-19

As millions more people become eligible for a fourth COVID vaccine dose, you might be asking whether you should book in for it or wait for Omicron-specific vaccines still being developed.

ABC News

Thinking of mixing and matching COVID-19 vaccine booster shots? There doesn't seem to be much point

Most people will have the Moderna or the Pfizer vaccine for their fourth dose. But the Doherty Institute's head of vaccine and immunisation research says there's practically no difference between them.

Get all your
news in one place.

100's of premium titles.
One news app.

Salon

Omicron boosters could be here by fall

As viruses morph and adapt, there's a greater call for targeted vaccines and boosters

The New Daily

COVID boosters: When Australians might be able to get their fourth jabs

With a third Omicron wave approaching, the wider Australian population may soon be able to get their second COVID booster shots.

Benzinga

This Is What Whales Are Betting On Moderna

The Conversation

COVID vaccines: our current shots could soon be updated to target new variants – an immunology expert explains

More than two years into the pandemic, SARS-CoV-2, the virus that causes COVID-19, continues to challenge us. Its ability to rapidly mutate has seen the evolution of increasingly infectious variants that are getting better at hiding from our immune response.

Benzinga

Peering Into Moderna's Recent Short Interest

Moderna's (NASDAQ:MRNA) short percent of float has fallen 4.65% since its last report. The company recently reported that it has 14.76 million shares sold short, which is 4.31% of all regular shares that are available for trading.

Chronicle Live

New 'super booster' Covid vaccine could be approved for use in UK within days

Moderna has created a new type of jab, codenamed 214, which is said to be more effective than previous vaccines, according to reports

Wales Online

30million people could get new Covid super booster codenamed 214

The jab engineered to tackle the new variants causing a summer wave is expected to be approved for use in the UK

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.